These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25597550)

  • 1. Verification of the biomarker candidates for non-small-cell lung cancer using a targeted proteomics approach.
    Kim YJ; Sertamo K; Pierrard MA; Mesmin C; Kim SY; Schlesser M; Berchem G; Domon B
    J Proteome Res; 2015 Mar; 14(3):1412-9. PubMed ID: 25597550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shotgun and Targeted Plasma Proteomics to Predict Prognosis of Non-Small Cell Lung Cancer.
    Li QR; Liu YS; Zeng R
    Methods Mol Biol; 2017; 1619():385-394. PubMed ID: 28674898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis for the discovery of lung cancer serological markers and validation by MRM-MS.
    Shin J; Song SY; Ahn HS; An BC; Choi YD; Yang EG; Na KJ; Lee ST; Park JI; Kim SY; Lee C; Lee SW
    PLoS One; 2017; 12(8):e0183896. PubMed ID: 28837649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
    Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
    J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
    Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
    J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline plasma proteomic analysis to identify biomarkers that predict radiation-induced lung toxicity in patients receiving radiation for non-small cell lung cancer.
    Cai XW; Shedden KA; Yuan SH; Davis MA; Xu LY; Xie CY; Fu XL; Lawrence TS; Lubman DM; Kong FM
    J Thorac Oncol; 2011 Jun; 6(6):1073-8. PubMed ID: 21532507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer.
    Huang LJ; Chen SX; Huang Y; Luo WJ; Jiang HH; Hu QH; Zhang PF; Yi H
    Lung Cancer; 2006 Oct; 54(1):87-94. PubMed ID: 16876904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum.
    Chambers AG; Percy AJ; Simon R; Borchers CH
    Expert Rev Proteomics; 2014 Apr; 11(2):137-48. PubMed ID: 24476379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification a novel clinical biomarker in early diagnosis of human non-small cell lung cancer.
    Jin Y; Yang Y; Su Y; Ye X; Liu W; Yang Q; Wang J; Fu X; Gong Y; Sun H
    Glycoconj J; 2019 Feb; 36(1):57-68. PubMed ID: 30607521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted proteomics pipeline reveals potential biomarkers for the diagnosis of metastatic lung cancer in pleural effusion.
    Chen CD; Wang CL; Yu CJ; Chien KY; Chen YT; Chen MC; Chang YS; Wu CC; Yu JS
    J Proteome Res; 2014 Jun; 13(6):2818-29. PubMed ID: 24787432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome.
    Wang CI; Wang CL; Wang CW; Chen CD; Wu CC; Liang Y; Tsai YH; Chang YS; Yu JS; Yu CJ
    Int J Cancer; 2011 May; 128(10):2364-72. PubMed ID: 20658535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma biomarkers distinguish non-small cell lung cancer from asthma and differ in men and women.
    Izbicka E; Streeper RT; Michalek JE; Louden CL; Diaz A; Campos DR
    Cancer Genomics Proteomics; 2012 Jan; 9(1):27-35. PubMed ID: 22210046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with non-small-cell lung cancer.
    Cai XW; Shedden K; Ao X; Davis M; Fu XL; Lawrence TS; Lubman DM; Kong FM
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):867-76. PubMed ID: 20510197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted proteomics strategy applied to biomarker evaluation.
    Kim YJ; Gallien S; van Oostrum J; Domon B
    Proteomics Clin Appl; 2013 Dec; 7(11-12):739-47. PubMed ID: 24123942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
    Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel detection method of non-small cell lung cancer using multiplexed bead-based serum biomarker profiling.
    Lee HJ; Kim YT; Park PJ; Shin YS; Kang KN; Kim Y; Kim CW
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):421-7. PubMed ID: 22104668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics analysis of human serum of patients with non-small-cell lung cancer reveals proteins as diagnostic biomarker candidates.
    Boccellino M; Pinto F; Ieluzzi V; Giovane A; Quagliuolo L; Fariello C; Coppola M; Carlucci A; Santini M; Ferati K; Bexheti-Ferati A; Giordano A; Di Domenico M
    J Cell Physiol; 2019 Dec; 234(12):23798-23806. PubMed ID: 31180588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of serum proteome components associated with progression of non-small cell lung cancer.
    Pietrowska M; Jelonek K; Michalak M; Roś M; Rodziewicz P; Chmielewska K; Polański K; Polańska J; Gdowicz-Kłosok A; Giglok M; Suwiński R; Tarnawski R; Dziadziuszko R; Rzyman W; Widłak P
    Acta Biochim Pol; 2014; 61(2):325-31. PubMed ID: 24872961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative targeted screening of proteins associated with lung adenocarcinoma cancer by the method of selected reaction monitoring].
    Kopylov AT; Tikhonova OV; Farafonova TE; Novikova SE; Shushkova NA; Shevchenko VE; Liao PC; Archakov AI; Zgoda VG
    Biomed Khim; 2018 Aug; 64(4):368-375. PubMed ID: 30135285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.